Nutritional care in children with cystic fibrosis: Are our patients becoming better?

European Journal of Clinical Nutrition

Volumn 67, Issue 5, 2013, Pages 558-564

  Gaskin, K J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

cystic fibrosis; nutrition; paediatrics; survival

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PANCREAS ENZYME; VITAMIN;

ALPHA TOCOPHEROL DEFICIENCY; CALORIC INTAKE; CF GENE; CHILD; CHILD GROWTH; CHILD NUTRITION; CHLORIDE TRANSPORT; CYSTIC FIBROSIS; DIET THERAPY; DIETARY COMPLIANCE; DIETARY REFERENCE INTAKE; EARLY DIAGNOSIS; ENERGY EXPENDITURE; ENZYME REPLACEMENT; GROWTH DISORDER; HUMAN; LIPID DIET; LUNG CLEARANCE; MACRONUTRIENT; MALABSORPTION; MALNUTRITION; NEWBORN SCREENING; NUTRITIONAL DEFICIENCY; PANCREAS INSUFFICIENCY; REVIEW; SURVIVAL RATE; SURVIVAL TIME; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

CHILD; CYSTIC FIBROSIS; DIET; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; ENERGY INTAKE; GROWTH; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; SURVIVORS; VITAMINS;

EID: 84877114403     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.20     Document Type: Review

References (69)

1. Quinton PM. Chloride impermeability in cystic fibrosis. Nature 1983; 301: 421-422
2. Gaskin KJ, Durie PR, Corey M, Wei P, Forstner G. Evidence for a primary defect in pancreatic HCO3 -secretion in cystic fibrosis. Pediatr Res 1982; 16: 554-557
3. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245: 1066-1072
4. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989; 245: 1059-1065
5. Bear CE, Li C, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992; 68: 809-818
6. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007; 29: 522-526
7. Corey ML. Longitudinal studies in cystic fibrosis. In: Sturgess JM (ed.) Perspectives in Cystic Fibrosis. The Imperial Press Ltd: Toronto, Canada, 1980, pp 246-255
8. Cystic Fibrosis Canada. Canadian Cystic Fibrosis Patient Data Registry report. 2009. http://www.cysticfibrosis.ca/assets/files/pdf/CPDR-ReportE.pdf (accessed August 2011
9. Phelan P, Hey E. Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-1980. Arch Dis Child 1984; 59: 71-73
10. Waters DL, Wilcken B, Irwig L, Van Asperen P, Mellis C, Simpson JM et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal 1999; 80: F1-F7
11. Berry HK, Kellogg FW, Hunt MM, Ingberg RL, Richter L, Gutjahr C. Dietary supplement and nutrition in children with cystic fibrosis. Am J Dis Child 1975; 129: 165-171
12. Durie PR, Bell L, Linton W, Corey ML, Forstner GG. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut 1980; 21: 778-786
13. Forstner GG, Gall G, Corey M, Durie PR, Hill RE, Gaskin KJ. Digestion and absorption of nutrients in cystic fibrosis. In: Sturgess J (ed.) Perspectives in Cystic Fibrosis: Proceedings of the 8th International Congress on Cystic Fibrosis. Imperial Press Ltd: Mississauga, ON, Canada, 1980, pp 137-148
14. Kuo PT, Huang NN. The effect of medium-chain triglycerides upon fat absorption and plasma lipids and deposition of fat of children with cystic fibrosis of the pancreas. J Clin Invest 1965; 44: 1924-1929
15. Soutter VL, Kristidis P, Gruca MA, Gaskin KJ. Chronic undernutrition, growth retardation in cystic fibrosis. Clin Gastroenterol 1986; 15: 137-155
16. Parsons HG, Beaudry P, Dumas A, Pencharz PG. Energy needs and growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983; 2: 44-49
17. Durie PR, Newth CJ, Forstner GG, Gall DG. Malabsorption of medium-chain triglycerides in infants with cystic fibrosis: Correction with pancreatic enzyme supplements. J Pediatr 1980; 96: 862-864
18. Duhamel DJ, Lenoir G, Brouard J. Prise en charge nutritionelle des nouveau-ne's et nourrissons atteints de fibrose kystique du pancre'as et dé piste's à la naissance. Proceedings of the International Conference on Neonatal Screening for Cystic Fibrosis.; 5-6 October 1988; University of Caen, Caen, France; pp 183-199
19. Bell L, Durie P, Forstner GG. What do children with cystic fibrosis eaẗJ Pediatr Gastroenterol Nutr 1984; 3(Suppl 1): 137-146
20. Roy CC, Darling P, Weber AM. A rational approach to meeting macro-And micronutrient needs in cystic fibrosis. J Pediatr Gastroenterol Nutr 1983; 3(Suppl 1): 154-162
21. Parsons HG, Beaudry P, Pencharz PB. The effect of nutritional rehabilitation on whole body protein metabolism of children with cystic fibrosis. Pediatr Res 1985; 19: 189-192
22. Shepherd R, Cooksley WG, Cooke WD. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr 1980; 97: 351-357
23. Levy LD, Durie PR, Pencharz PB, Corey ML. Effects of long-Term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr 1985; 107: 225-230
24. Boland MP, Stoski DS, MacDonald NE, Soucy P, Patrick J. Chronic jejunostomy feeding with a non-elemental formula in undernourished patients with cystic fibrosis. Lancet 1986; 1: 232-234
25. Gaskin KJ. The impact of nutrition in cystic fibrosis: A review. J Pediatr Gastroenterol Nutr 1988; 7(Suppl 1): S12-S17
26. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 588-591
27. Gaskin KJ, Allen Jr. Exocrine pancreatic disease including cystic fibrosis In: Duggan C, Watkins JB, Walker WA (eds). Nutrition in Pediatrics. 4th edn. (BC Decker Inc.: Hamilton, ON, Canada, 2008, pp 577-588
28. McKay KO, Waters DL, Gaskin KJ. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales. J Pediatr 2004; 147: S47-S50
29. Dijk FN, McKay K, Barzi F, Gaskin KJ, Fitzgerald DA. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre. Arch Dis Child 2011; 96: 1118-1123
30. Baur LA, Allen JR, Waters DL, Gaskin KJ. Total body nitrogen in prepubertal children. In: Ellis KJ, Eastman JD (eds) Human Body Composition. Plenum Press: New York, NY, USA, 1993, pp 139-142
31. Haas VK, Allen JR, Kohn MR, Clarke SD, Zhang S-H, Briody JN et al. Total body protein in healthy adolescent girls: Validation of estimates derived from simpler measures with neutron activation analysis. Am J Clin Nutr 2007; 85: 66-72
32. Baur LA, Waters DL, Allen BJ, Blagojevic N, Gaskin KJ. Nitrogen deposition in malnourished children with cystic fibrosis. Am J Clin Nutr 1991; 53: 503-511
33. Gaskin KJ, Gurwitz D, Durie PR, Corey M, Levison H, Forstner G. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 1982; 100: 857-862
34. Gaskin KJ, Durie PR, Hill RE, Lee L, Forstner G. Colipase and maximally activated pancreatic lipase in normal subjects and patients with steatorrhea. J Clin Invest 1982; 69: 427-434
35. Gaskin KJ, Durie PR, Hill RE, Lee L, Forstner G. Colipase and lipase secretion in childhood onset pancreatic insufficiency: Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology 1984; 86: 1-7
36. Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H et al. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr 1995; 127: 705-710
37. Waters DL, Dorney S, Gaskin K, Gruca M, O'Halloran M, Wilcken B. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med 1990; 322: 303-308
38. Gaskin K, Waters D, Dorney S, Gruca M, O'Halloran M, Wilcken B. Assessment of pancreatic function in screened infants with cystic fibrosis. Pediatr Pulmonol Suppl 1991; 7: 69-71
39. Cipolli M, Castellani C, Wilcken B, Massie J, McKay K, Gruca M et al. Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening. Arch Dis Child 2007; 92: 842-846
40. Lapey A, Kirkpatrick J, di Sant'Agnese P, Laster L. Steatorrhoea and azotorrhoea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis. J Pediatr 1974; 84: 328-334
41. Mitchell EA, Quested C, Marks RD, Pinnock RE, Elliott RB. Comparative trial of viokase, pancreatin and Pancreases pancrelipase (enteric-coated beads) in the treatment of malabsorption in cystic fibrosis. Aust Paediatr J 1982; 18: 114-117
42. Gow R, Bradbear R, Francis P, Shepherd RW. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis. Lancet 1981; 1: 1071-1074
43. Gaskin KJ. Impact of nutrition in cystic fibrosis. A review. J Pediatr Gastroenterol Nutr 1988; 7(Suppl 1): 12-17
44. Holliday KE, Allen JR, Waters DL, Gruca MA, Thompson SM, Gaskin KJ. Growth of human milk-fed and formula-fed infants with cystic fibrosis. J Pediatr 1991; 118: 77-79
45. Feigel RJ, Shapiro BL. Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis. Nature 1979; 178: 276-277
46. Stutts MJ, Knowles MR, Gatzy JT, Boucher RC. Oxygen consumption and ouabain binding-sites in cystic fibrosis nasal epithelium. Pediatr Res 1986; 20: 1316-1320
47. Pencharz P, Hill R, Archibald E, Levy L, Newth C. Energy needs and nutritional rehabilitation in undernourished adolescents and adults with cystic fibrosis. J Pediatr Gastroenterol Nutr 1984; 3(Suppl 1): 147-153
48. Vaisman N, Pencharz PB, Corey M, Canny GJ, Hahn E. Energy expenditure of patients with cystic fibrosis. J Pediatr 1987; 111: 496-500
49. Buchdahl RM, Cox M, Fulleylove C, Marchant JL, Tomkins AM, Brueton MJ et al. Increased resting energy expenditure in cystic fibrosis. J Appl Physiol 1988; 64: 1810-1816
50. Shepherd RW, Holt TL, Vasques-Velasquez L, Coward WA, Prentice A, Lucas A. Increased energy expenditure in children with cystic fibrosis. Lancet 1988; 1: 1300-1303
51. O'Rawe A, McIntosh I, Dodge JA, Brock DJ, Redmond AO, Ward R et al. Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clin Sci 1992; 82: 71-76
52. Fried MD, Durie PR, Tsui LC, Corey M, Levison H, Pencharz PB. The cystic fibrosis gene and resting energy expenditure. J Pediatr 1991; 119: 913-916
53. Allen JR, McCauley J, Selby A, Waters DL, Gruca MA, Gaskin KJ. Differences in resting energy expenditure between male and female children with cystic fibrosis. J Pediatr 2003; 142: 15-19
54. Magoffin A, Allen JR, McCauley J, Gruca M, Peat J, Van Asperen P et al. Longitudinal analysis of resting energy expenditure in patients with cystic fibrosis. J Pediatr 2008; 152: 703-708
55. Barclay A, Allen JR, Blyler E, Prior R, Yap J, Gruca MA et al. Resting energy expenditure in females with cystic fibrosis -is it affected by pubertÿEur J Clin Nutr 2007; 61: 1207-1212
56. Stallings VA. (Editorial) Gender, death and cystic fibrosis: Is energy expenditure a componenẗJ Pediatr 2003; 142: 4-6
57. Abernathy RS. Bulging fontanelle as presenting sign in csystic fibrosis. Am J Dis Child 1976; 130: 1360-1362
58. Rayner RJ, Tyrell JC, Hiller EJ, Marenah C, Neugebauer MA, Vernon SA et al. Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis. Arch Dis Child 1989; 64: 1151-1156
59. Scott J, Elias E, Moult PJA, Barnes S, Wills MR. Rickets in adult cystic fibrosis with myopathy, pancreatic insufficiency and proximal renal tubular dysfunction. Am J Med 1977; 63: 488-492
60. Hubbard VS, Farrell PM, di Sant'Agnese PA. 25-Hydroxycholecalciferol levels in patients with cystic fibrosis. J Pediatr 1979; 94: 84-86
61. Reiter EO, Brugman SM, Pike JW, Pitt M, Dokoh S, Haussler MR et al. Vitamin D metabolites in adolescents and young adults with cystic fibrosis: Effects of sun and season. J Pediatr 1985; 106: 21-25
62. Farrell PM, Bieri JG, Fratantoni JF, Wood RE, di Sant'Agnese PA. The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis. J Clin Invest 1977; 60: 233-241
63. Elias E, Müller DPR, Scott J. Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and low serum vitamin E. Lancet 1981; 2: 1319-1321
64. Sitrin MD, Lieberman F, Jensen WE, Noronha A, Milburn C, Addington W. Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Ann Intern Med 1987; 107: 51-54
65. Sokol RJ, Reardon MC, Accurso FJ, Stall C, Narkewicz M, Abman SH et al. Fat-soluble vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 1989; 50: 1064-1071
66. Komp DM, Selden RF. Coagulation abnormalities in cystic fibrosis. Chest 1970; 58: 501-508
67. Walters TR, Koch HF. Hemorrhagic diathesis and cystic fibrosis in infancy. Am J Dis Child 1972; 124: 641-647
68. Shepherd RW, Holt TL, Thomas BJ, Kay L, Isles A, Francis PJ et al. Nutritional rehabilitation in cystic fibrosis: Controlled studies of the effects on nutritional growth retardation, body protein turnover and course of pulmonary disease. J Pediatr 1986; 109: 788-794
69. Gunnell S, Christensen NK, McDonald C, Jackson D. Attitudes towards percutaneous endoscopic gastrostomy placement in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 2005; 40: 334-338